Get the Stockscreener App
16.00
0.62%
-0.10
After Hours:
16.00
Abrdn Life Sciences Investors stock is traded at $16.00, with a volume of 243.95K.
It is down -0.62% in the last 24 hours and up +13.23% over the past month.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
See More
Previous Close:
$16.10
Open:
$16.19
24h Volume:
243.95K
Relative Volume:
1.75
Market Cap:
$461.96M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.46%
1M Performance:
+13.23%
6M Performance:
+43.63%
1Y Performance:
+7.82%
1-Day Range:
$15.83
$16.20
1-Week Range:
$15.60
$16.23
52-Week Range:
$10.55
$16.23
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Name
Abrdn Life Sciences Investors
Sector
Industry
Phone
-
Address
-
Compare HQL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
16.00 | 464.85M | 0 | 0 | 0 | 0.00 |
|
DNP
Dnp Select Income Fund Inc
|
9.93 | 3.71B | 0 | 0 | 0 | 0.00 |
|
UTG
Reaves Utility Income Fund
|
40.31 | 3.65B | 0 | 0 | 0 | 0.00 |
|
ADX
Adams Diversified Equity Fund
|
22.12 | 2.72B | 0 | 0 | 0 | 0.00 |
|
ETY
Eaton Vance Tax Managed Diversified Equity Income Fund
|
15.51 | 2.49B | 0 | 0 | 0 | 0.00 |
|
GDV
Gabelli Dividend Income Trust
|
26.53 | 2.40B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors Stock (HQL) Latest News
Abrdn Life Sciences Investors stock prediction for this weekJuly 2025 Highlights & Growth Oriented Trade Recommendations - newser.com
How to escape a deep drawdown in Abrdn Life Sciences Investors2025 Historical Comparison & Risk Controlled Daily Plans - newser.com
Will abrdn Life Sciences Investors Shares stock outperform benchmarksEarnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com
Can abrdn Life Sciences Investors Shares stock sustain revenue momentumChart Signals & Free Accurate Trade Setup Notifications - newser.com
Why abrdn Life Sciences Investors Shares stock could be top winnerWeekly Gains Report & Reliable Intraday Trade Plans - newser.com
Can swing trading help recover from Abrdn Life Sciences Investors lossesJuly 2025 Sentiment & Accurate Buy Signal Notifications - newser.com
Will Abrdn Life Sciences Investors stock maintain growth storyJuly 2025 Gainers & Technical Pattern Based Buy Signals - newser.com
Candlestick signals on Abrdn Life Sciences Investors stock todayJuly 2025 Big Picture & Growth-Oriented Investment Plans - newser.com
Published on: 2025-10-05 05:50:21 - newser.com
Can Abrdn Life Sciences Investors stock beat analyst upgrades2025 Key Lessons & Fast Gain Stock Tips - newser.com
Does Abrdn Life Sciences Investors stock trade at a discount to peersWeekly Trend Report & Risk Adjusted Swing Trade Ideas - newser.com
abrdn Life Sciences Investors (NYSE:HQL) Sees Significant Drop in Short Interest - MarketBeat
Using data filters to optimize entry into Abrdn Life Sciences Investors2025 Key Highlights & Reliable Price Breakout Signals - newser.com
abrdn Life Sciences Investors (NYSE:HQL) Trading 1.6% HigherHere's What Happened - MarketBeat
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS - PR Newswire
What drives Abrdn Life Sciences Investors stock priceIndustrial Stocks Review & Free Rapid Portfolio Appreciation - earlytimes.in
Does Abrdn Healthcare Investors qualify in momentum factor screeningIndex Update & Weekly Top Stock Performers List - newser.com
What analysts say about Abrdn Life Sciences Investors stockPrice Volatility Patterns & Subscribe for Free Weekly Winners - earlytimes.in
Saba Capital Management, L.P. Adjusts Position in abrdn Life Sci - GuruFocus
Historical volatility pattern of Abrdn Healthcare Investors visualizedBull Run & Consistent Return Strategy Ideas - newser.com
Abrdn Life Sciences Investors Stock (HQL) Financials Data
There is no financial data for Abrdn Life Sciences Investors (HQL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):